Ajay Patel Sells Shares of ASRT

Ajay Patel, the Executive Vice President and Chief Financial Officer of ASRT, sold 15,942 shares on June 16, 2026. The transaction was not part of a pre-planned trading program, and shares of ASRT were trading near $23.50 at the time of the sale.

Insider Buying and Selling at ASRT

On the same day, several other insiders also sold shares. Kirk Sigurd sold 12,017 shares, David Matthew Stark sold 11,420 shares, and Paul Schwichtenberg, the President and COO, sold 32,042 shares. William McKee sold 27,936 shares, and Sravan Kumar Emany sold 23,855 shares. None of these transactions were under pre-arranged trading plans.

Other Institutional Activity in ASRT

Among institutional investors, Nantahala Capital Management increased its holdings by 105,000 shares, reaching a total of 692,335 shares valued at approximately $13.2 million. Vanguard Capital Management also added to its position with 268,952 shares worth about $5.1 million. On the other hand, Opaleye Management reduced its stake by 19,293 shares, ending with 265,707 shares valued at about $5.1 million. Renaissance Technologies added 37,902 shares, bringing its total to 228,599 shares worth around $4.4 million.

ASRT Stock Snapshot

Shares of ASRT traded around $23.50. The stock has a 52-week range between $20.00 and $25.00. Investors keep an eye on these figures to gauge market sentiment and potential volatility.

Analysts Set New Price Targets

On May 13, 2026, Lake Street maintained a hold rating on ASRT with a price target of $23.50. Earlier, on May 5, 2026, HC Wainwright & Co. also maintained a hold rating, setting a target of $21.80. These ratings help provide a context for potential investors looking at ASRT's market position.

About ASRT

ASRT is a company involved in the healthcare sector, focusing on providing therapeutic solutions. The company is known for its work in developing and marketing pharmaceutical products. ASRT operates with a mission to improve patient outcomes through its innovative products and services.

Bottom Line

Ajay Patel's recent sale of ASRT shares is part of a broader trend of insider transactions on June 16, 2026. While insiders selling shares can be noteworthy, it's important to view these actions in the context of the company's overall performance and market conditions. Investors often track such insider activities as part of their broader analysis of a company's health and future prospects.